New Genetics and Society

Papers
(The TQCC of New Genetics and Society is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
The speculative turn in IVF: egg freezing and the financialization of fertility44
Genome editing: the dynamics of continuity, convergence, and change in the engineering of life19
I am a Viking! DNA, popular culture and the construction of geneticized identity16
A cold yield. Cryopreserved oocytes of “social freezing” customers as potential option values for biomedical research13
Thinking the unthinkable: how did human germline genome editing become ethically acceptable?12
Transparency, consent and trust in the use of customers' data by an online genetic testing company: an Exploratory survey among 23andMe users10
Problematizing consent: searching genetic genealogy databases for law enforcement purposes10
Beyond nosology? Molecular tumor boards, singularization, and the conflation of diagnosis and therapy9
The consumer representation of DNA ancestry testing on YouTube9
Long-range familial searches in recreational DNA databases: expansion of affected populations, the participatory turn, and the co-production of biovalue8
Opening up forensic DNA phenotyping: the logics of accuracy, commonality and valuing8
The welfare state driving “me” and “we” medicine – a critical discourse analysis7
Decision-making about non-invasive prenatal testing: women’s moral reasoning in the absence of a risk of miscarriage in Germany7
The somatic mode: doing good in targeted cancer therapy7
Past-futures in experimental care: breast cancer and HIV medicine7
The platforming of human embryo editing: prospecting “disease free” futures6
Organizing precision oncology: introduction to the special issue6
Genetic ancestry testing, whiteness and the limits of anti-racism6
Data curation-research: practices of data standardization and exploration in a precision medicine database5
Putting menopause on ice: the cryomedicalization of reproductive aging5
A feeling for the (micro)organism? Yeastiness, organism agnosticism and whole genome synthesis5
The omics of our lives: practices and policies of direct-to-consumer epigenetic and microbiomic testing companies5
Beyond full jurisdiction: pathology and inter-professional relations in precision medicine4
Accessing targeted therapies for cancer: self and collective advocacy alongside and beyond mainstream cancer charities4
The new stage of public engagement with science in the digital media environment: citizen science communicators in the discussion of GMOs on Zhihu4
The social shaping of a diagnosis in Next Generation Sequencing4
Organizing the precision clinic: arranging expertise, knowledge and technologies in cancer precision medicine clinical trials4
Promising precision medicine: how patients, clinicians and caregivers work to realize the potential of genomics-informed cancer care4
The rise of the biocyborg: synthetic biology, artificial chimerism and human enhancement4
0.050864934921265